Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

General v. specific indications

This article was originally published in The Gray Sheet

Executive Summary

DCRD initiative to allow general use labeling for electrophysiology catheters may also be applicable to other well established technologies. The division plans to allow cardiac ablation catheters to use a general indication for treatment of arrhythmias, rather than requiring PMA supplements for each individual application (1"The Gray Sheet," Jan. 8, 2001, p. 6). "We're taking a good hard look at some of those technologies that may be 10, 15 or 20 years old and have multiple singular indications associated where can we bring them together to have a more generic indication for use," Dillard says. Grouping indications, "so that we're only looking at one application as opposed to multiple applications," will serve to decrease the division's workload

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015083

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel